Avid Bioservices, Inc. (CDMOP) Trades at $25.15 After Triangle; Mainstreet Equity Corp. (TSE:MEQ) Had 0 Analysts Last Week

Among 2 analysts covering Mainstreet Equity Corp. (TSE:MEQ), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Mainstreet Equity Corp. had 6 analyst reports since December 11, 2015 according to SRatingsIntel. The firm has “Hold” rating by TD Securities given on Thursday, December 8. See Mainstreet Equity Corp. (TSE:MEQ) latest ratings:

Avid Bioservices, Inc. (CDMOP) formed triangle with $24.14 target or 4.00% below today’s $25.15 share price. Avid Bioservices, Inc. (CDMOP) has $185.35 million valuation. The stock increased 1.31% or $0.33 during the last trading session, reaching $25.15. About 1,699 shares traded or 29.60% up from the average. Avid Bioservices, Inc. (NASDAQ:CDMOP) has 0.00% since April 26, 2017 and is . It has underperformed by 11.55% the S&P500.

The stock decreased 2.40% or $1 during the last trading session, reaching $40.6. About 626 shares traded. Mainstreet Equity Corp. (TSE:MEQ) has 0.00% since April 26, 2017 and is . It has underperformed by 11.55% the S&P500.

Mainstreet Equity Corp., a real estate corporation, engages in the acquisition, divestiture, value-enhancement, and management of multi-family residential properties primarily in Western Canada. The company has market cap of $358.59 million. The firm owns a portfolio of mid-market rental apartment buildings in Vancouver lower mainland, Calgary, Edmonton, and Saskatoon. It has a 4.03 P/E ratio. As of September 30, 2016, it had a total portfolio of 9,878 residential units consisting of townhouses, garden-style apartments, and midrise and high-rise apartments.